BioPharma Credit PLC NOTICE OF FULL YEAR RESULTS (4013R)
01 Março 2023 - 4:00AM
UK Regulatory
TIDMBPCR
RNS Number : 4013R
BioPharma Credit PLC
01 March 2023
1 March 2023
BIOPHARMA CREDIT PLC
(the "Company")
NOTICE OF FULL YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences
debt investor, will announce its audited Full Year Results for the
period ending 31 December 2022 on Wednesday 22 March 2023.
A management presentation will be delivered at 9:30am GMT at the
offices of Buchanan, 107 Cheapside, EC2V 6DN and through a webcast
facility for those unable to attend in person. To register to
attend or request details, RSVP to biopharmacredit@buchanan.uk.com
.
-Ends-
Enquiries
BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0) 1392 477 500
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORZZGZZNRDGFZM
(END) Dow Jones Newswires
March 01, 2023 02:00 ET (07:00 GMT)
Biopharma Credit (LSE:BPCP)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Biopharma Credit (LSE:BPCP)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024